-
Institut de Recerca Sant Joan de Déu's Christmas card
Institut de Recerca Sant Joan de Déu & Research Foundation Sant Joan de Déu wish you Merry Christmas and a Happy New Year.
-
Professionals at Sant Joan de Déu make it easier for doctors around the world to diagnose a rare disease
They analysed the most remarkable traits of children suffering from PMM2-CDG and designed an app that uses a photograph of the patient's face to suggest a diagnosis.
-
Sant Joan de Déu seeks young patients and caregivers to create the first pediatric expert patient database
People registered on this platform will help to include the vision of patients in the process of developing clinical trials in pediatrics. In all activities, the participation of pediatric patients will be prioritized and, when this is not possible, that of their caregivers.
This initiative is part of the "Conect4Children" (c4c) project, a collaborative network created to conduct pediatric clinical trials in Europe.
-
Research in childhood cancer at the Institut de Recerca Sant Joan de Déu cover of Science Translational Medicine journal
The results of the research, which describes a new treatment of retinoblastoma, has been published by Science Translational Medicine and reviewed by the journal Science.
A team of researchers from Institut de Recerca Sant Joan de Déu and SJD Barcelona Children's Hospital has developed a new experimental treatment for retinoblastoma or tumour of the retina, a disease that accounts for 11% of malignancies in children under one year old.
-
Institut de Recerca Sant Joan de Déu's Christmas card
Institut de Recerca Sant Joan de Déu & Research Foundation Sant Joan de Déu wish you, Merry Christmas and a Happy New Year.
-
Research Foundation's Christmas card
Research Foundation Sant Joan de Déu wishes you, Merry Christmas and a Happy New Year.
-
First study showing improved drug levels in pediatric tumor microenvironment upon antibody-mediated nanoparticle release
A new study describes a novel approach for understanding intratumoral distribution of tumor-targeted anticancer drugs. The work produced clinically relevant data that open new opportunities for patients with neuroblastoma.
The work was an international collaboration between Institut de Recerca Sant Joan de Déu (Barcelona, Spain), Technion – Israel Institute of Technology (Haifa, Israel) and Memorial Sloan Kettering Cancer Center (MSKCC, New York, USA). The findings appeared in the Journal of Controlled Release.
-
New potential target found for diffuse intrinsic pontine glioma (DIPG)
A new study from the University of Copenhagen (Biotech Research and Innovation Centre – BRIC -) and Sant Joan de Deu (Pediatric Hematology and Oncology) expands understanding of the genetic basis of DIPG and identifies EZH2 as possible target.
-
Resolution of the service offer: Suport in the Harmonisation Process